Sanofi and Merck’s Hexavalent Combination Vaccine Approved for the Prevention of Multiple Diseases in Pediatrics
Sanofi has announced that the FDA has approved Vaxelis, a full-liquid ready-to-use hexavalent combination vaccine for infants from 6 weeks old to 4 years old (before the 5th birthday). The vaccine isRead More…